Skip to main content
Premium Trial:

Request an Annual Quote

Michael Cavanaugh, Brent Keller, Mathew Hahn, Stone Bond Technologies, Protagen, TeleChem International

Premium

People in the News

Michael Cavanaugh has joined Laureate Pharma as vice president of sales, marketing, and business development, the Princeton, NJ-based company said last week. He used to be vice president of marketing and sales support for North America with Amersham/GE Healthcare, where he was responsible for products that included instruments and reagents for genomics, proteomics, screening, cellular analysis, and preclinical imaging. Prior to that, he was senior director of business development Europe at Gene Logic. Cavanaugh holds a master's degree in clinical microbiology with a minor in biochemistry from Hahnemann Medical College in Philadelphia and a BS in biology with a minor in chemistry from Fairfield University, in Connecticut.


Brent Keller has been appointed as general manager of Kreatech Biotechnology USA, Kreatech's new San Diego-based US office, the Amsterdam, Netherlands-based company said yesterday. He is currently Kreatech's vice president for commercial operations, working for the company parttime. He holds an MBA in strategic planning and marketing from Pepperdine University and a BS in biology, along with graduate training in viral immunology, from Rensselaer Polytechnic Institute.


Mathew Hahn has been promoted to chief science and technology officer of Accelrys, the company said last week. Hahn, a co-founder of SciTegic, which Accelrys acquired in 2004, will remain general manager of the SciTegic subsidiary. Han holds a PhD from the University of Santa Cruz.

 

New Product Watch

Stone Bond Technologies last week released Microarray Quick Start, a lab information management system that the Houston-based software company claims "can be implemented in a matter of days" and is being marketed to microarray core research facilities.

Stone Bond said the new LIMS package "streamlines core operations procedures," including lab requests, patient and grant billings, materials tracking and load balancing.


Protagen said last week that its UNIchip AV-400 and UNIchip AV-VAR protein microarrays are now available.

The Dortmund, Germany-based firm said that the arrays are primarily designed for antibody validation, but can also be used with antibody-like molecules like affibodies or aptamers.

According to Protagen, the UNIchip AV-400 contains 400 pre-defined and purified human proteins on a nitrocellulose-coated glass slide, which represent a cross-section of all cellular proteins.

The company said that the 400 proteins are focused on different gene ontology classes, which can be customized by the user.


TeleChem International has added dehumidification and interstitial printing features to its NanoPrint microarray spotters, the Sunnyvale, Calif.-based firm said last month.

TeleChem claims that the upgraded NanoPrint now has the first "fully active humidity control system to both add and remove humidity from the microarraying chamber." The interstitial printing feature combined with the humidification system will allow users to print higher density arrays, TeleChem said.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.